Functionalized ZIF‐90 for Gene‐mediated Chemotherapy to Ameliorate Multidrug Resistance in Breast Cancer Therapy. Issue 2 (10th November 2021)
- Record Type:
- Journal Article
- Title:
- Functionalized ZIF‐90 for Gene‐mediated Chemotherapy to Ameliorate Multidrug Resistance in Breast Cancer Therapy. Issue 2 (10th November 2021)
- Main Title:
- Functionalized ZIF‐90 for Gene‐mediated Chemotherapy to Ameliorate Multidrug Resistance in Breast Cancer Therapy
- Authors:
- Gong, Senyi
Shang, Mengdi
Li, Dawei
Cai, Yanfei
Jin, Jian
Yang, Zhaoqi - Abstract:
- Abstract: Breast cancer, the most common cancer, is a threat to women's health. A great challenge for breast cancer is the multidrug resistance (MDR) problem. P‐glycoprotein (P‐gp) is one of main reasons to induce MDR in the therapy of breast cancer. A novel nanosystem based on ZIF‐90 was developed for alleviating MDR and to improve the therapeutic efficacy. In this investigation, ZIF‐90 was used as a carrier to deliver two kinds of DNA molecular beacons (MBs) and Doxorubicin (Dox). The loop sequences of two kinds of MBs were designed to specifically hybridize with the mRNAs related to P‐gp (MDR1 gene and ETS1 gene, respectively), thereby directly inhibiting the expression of downstream proteins P‐gp. The results of confocal fluorescence imaging and qRT‐PCR analysis indicated that MB and Dox were delivered into cells and the mRNAs related to P‐gp were silenced. The MTT assay showed that the IC50 of nanosystem to the drug‐resistant breast cancer cells (34.78 μg/mL) was much lower than the IC50 of Dox to the same cells (152.7 μg/mL). These results distinctly confirmed that the problem of MDR has been ameliorated by our designed nanosystem. It is our hope that this investigation may provide a new treatment strategy for enhancing the therapeutic efficacy of chemotherapy for breast cancer. Abstract : A novel nanosystem based on ZIF‐90 was developed for alleviating the MDR problem .Two kinds of MB were designed to specifically hybridize with the mRNAs related to P‐gp (MDR1 geneAbstract: Breast cancer, the most common cancer, is a threat to women's health. A great challenge for breast cancer is the multidrug resistance (MDR) problem. P‐glycoprotein (P‐gp) is one of main reasons to induce MDR in the therapy of breast cancer. A novel nanosystem based on ZIF‐90 was developed for alleviating MDR and to improve the therapeutic efficacy. In this investigation, ZIF‐90 was used as a carrier to deliver two kinds of DNA molecular beacons (MBs) and Doxorubicin (Dox). The loop sequences of two kinds of MBs were designed to specifically hybridize with the mRNAs related to P‐gp (MDR1 gene and ETS1 gene, respectively), thereby directly inhibiting the expression of downstream proteins P‐gp. The results of confocal fluorescence imaging and qRT‐PCR analysis indicated that MB and Dox were delivered into cells and the mRNAs related to P‐gp were silenced. The MTT assay showed that the IC50 of nanosystem to the drug‐resistant breast cancer cells (34.78 μg/mL) was much lower than the IC50 of Dox to the same cells (152.7 μg/mL). These results distinctly confirmed that the problem of MDR has been ameliorated by our designed nanosystem. It is our hope that this investigation may provide a new treatment strategy for enhancing the therapeutic efficacy of chemotherapy for breast cancer. Abstract : A novel nanosystem based on ZIF‐90 was developed for alleviating the MDR problem .Two kinds of MB were designed to specifically hybridize with the mRNAs related to P‐gp (MDR1 gene and ETS1 gene respectively). The results distinctly confirmed that the problem of MDR has been ameliorated by the designed nanosystem. … (more)
- Is Part Of:
- ChemNanoMat. Volume 8:Issue 2(2022)
- Journal:
- ChemNanoMat
- Issue:
- Volume 8:Issue 2(2022)
- Issue Display:
- Volume 8, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 8
- Issue:
- 2
- Issue Sort Value:
- 2022-0008-0002-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-11-10
- Subjects:
- multidrug resistance -- P-glycoprotein -- gene silencing -- breast cancer -- ZIF-90
Nanochemistry -- Periodicals
Nanostructured materials -- Periodicals
Nanochemistry
Nanostructured materials
Periodicals
541.2 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2199-692X/issues ↗
http://resolver.library.ualberta.ca/resolver?ctx_enc=info%3Aofi%2Fenc%3AUTF-8&ctx_ver=Z39.88-2004&rfr_id=info%3Asid%2Fualberta.ca%3Aopac&rft.genre=journal&rft.object_id=4200000000000019&rft.issn=2199-692X&rft.eissn=&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&url_ctx_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Actx&url_ver=Z39.88-2004 ↗
http://resolver.lrc.macewan.ca/macewan?url%5Fver=Z39.88-2004&ctx%5Fver=Z39.88-2004&ctx%5Fenc=info:ofi/enc:UTF-8&rfr%5Fid=info:sid/sfxit.com:opac%5F856&url%5Fctx%5Ffmt=info:ofi/fmt:kev:mtx:ctx&sfx.ignore%5Fdate%5Fthreshold=1&rft.object%5Fid=4200000000000019&svc%5Fval%5Ffmt=info:ofi/fmt:kev:mtx:sch%5Fsvc& ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cnma.202100389 ↗
- Languages:
- English
- ISSNs:
- 2199-692X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.255010
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20783.xml